Jared Gollob Kymera Therapeutics, Inc. (KYMR) insider trading activity

KYMR Quotes by TradingView

Jared Gollob is Chief Medical Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 120,000 shares of KYMR, which is worth approximately $3.55 Million. The most recent transaction as insider was on Feb 23, 2021, when has been sold 19,285 shares (Common Stock) at a price of $49.65 per share, resulting in proceeds of $957,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 120K
25.69% 3M change
25.34% 12M change
Total Value Held $3.55 Million

Jared Gollob Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 23 2021
SELL
Open market or private sale
$957,500 $49.65 p/Share
19,285 Reduced 25.54%
56,222 Common Stock
Feb 22 2021
SELL
Open market or private sale
$479,144 $52.63 p/Share
9,104 Reduced 10.76%
75,507 Common Stock
Feb 19 2021
SELL
Open market or private sale
$489,585 $55.09 p/Share
8,887 Reduced 9.51%
84,611 Common Stock
Feb 18 2021
SELL
Open market or private sale
$363,554 $55.94 p/Share
6,499 Reduced 6.5%
93,498 Common Stock
Feb 17 2021
SELL
Open market or private sale
$440,844 $58.39 p/Share
7,550 Reduced 7.02%
99,997 Common Stock
JG

Jared Gollob

Chief Medical Officer
Watertown, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KYMR